Silencing of amyloid precursor protein expression using a new engineered delta ribozyme

International Journal of Alzheimer's Disease

Volumn , Issue , 2012, Pages

  Ben Aissa, Manel ^a   April, Marie Claude ^b   Bergeron, Lucien Junior ^b   Perreault, Jean Pierre ^b   Levesque, Georges ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; DELTA RIBOZYME; MESSENGER RNA; RIBOZYME; RNA; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; GENE SILENCING; GENETIC ENGINEERING; HEPATITIS DELTA VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84858214629     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.1155/2012/947147     Document Type: Article

References (55)

1. Levesque G., Sherrington R., St George-Hyslop P., Molecular Genetic of Alzheimer Disease 2002 Amsterdam, The Netherlands Elsevier Science
2. Hardy J., Selkoe D. J., The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 2002 297 5580 353 356 (Pubitemid 34790756)
3. Citron M., Eckman C. B., Diehl T. S., Corcoran C., Ostaszewski B. L., Xia W., Levesque G., Hyslop P. S. G., Younkin S. G., Selkoe D. J., Additive effects of PS1 and APP mutations on secretion of the 42- residue amyloid -protein Neurobiology of Disease 1998 5 2 107 116 (Pubitemid 28430721)
4. Citron M., Westaway D., Xia W., Carlson G., Diehl T., Levesque G., Johnson-Wood K., Lee M., Seubert P., Davis A., Kholodenko D., Motter R., Sherrington R., Perry B., Yao H., Strome R., Lieberburg I., Rommens J., Kim S., Schenk D., Fraser P., George H. P. S., Selkoe D. J., Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid -protein in both transfected cells and transgenic mice Nature Medicine 1997 3 1 67 72 (Pubitemid 27019143)
5. Holtzman D. M., Fagan A. M., Mackey B., Tenkova T., Sartorius L., Paul S. M., Bales K., Ashe K. H., Irizarry M. C., Hyman B. T., Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model Annals of Neurology 2000 47 6 739 747 (Pubitemid 30390194)
6. Deane R., Sagare A., Hamm K., Parisi M., Lane S., Finn M. B., Holtzman D. M., Zlokovic B. V., apoE isoform-specific disruption of amyloid peptide clearance from mouse brain Journal of Clinical Investigation 2008 118 12 4002 4013
7. Asif-Ullah M., Lévesque M., Robichaud G., Perreault J. P., Development of ribozyme-based gene-inactivations; the example of the hepatitis delta virus ribozyme Current Gene Therapy 2007 7 3 205 216 (Pubitemid 46902202)
8. Lévesque D., Choufani S., Perreault J. P., Delta ribozyme benefits from a good stability in vitro that becomes outstanding in vivo RNA 2002 8 4 464 477 (Pubitemid 34437717)
9. Bergeron L. J., Perreault J. P., Target-dependent on/off switch increases ribozyme fidelity Nucleic Acids Research 2005 33 4 1240 1248 (Pubitemid 41439917)
10. Bergeron L., Reymond C., Perreault J. P., Functional characterization of the SOFA delta ribozyme RNA 2005 11 12 1858 1868 (Pubitemid 41720035)
11. Robichaud G. A., Perreault J. P., Ouellette R. J., Development of an isoform-specific gene suppression system: the study of the human Pax-5B transcriptional element Nucleic Acids Research 2008 36 14 4609 4620
12. Fiola K., Perreault J. P., Cousineau B., Gene targeting in the gram-positive bacterium Lactococcus lactis, using various delta ribozymes Applied and Environmental Microbiology 2006 72 1 869 879
13. Lévesque M. V., Lévesque D., Brire F. P., Perreault J. P., Investigating a new generation of ribozymes in order to target HCV PLoS ONE 2010 5 3
14. Reymond C., Bisaillon M., Perreault J. P., Monitoring of an RNA multistep folding pathway by isothermal titration calorimetry Biophysical Journal 2009 96 1 132 140
15. Bergeron L. J., Perreault J. P., Development and comparison of procedures for the selection of delta ribozyme cleavage sites within the hepatitis B virus Nucleic Acids Research 2002 30 21 4682 4691 (Pubitemid 35331750)
16. Hébert S. S., Bourdages V., Godin C., Ferland M., Carreau M., Lévesque G., Presenilin-1 interacts directly with the -site amyloid protein precursor cleaving enzyme (BACE1) Neurobiology of Disease 2003 13 3 238 245 (Pubitemid 36939188)
17. Yu Q., Pecchia D. B., Kingsley S. L., Heckman J. E., Burke J. M., Cleavage of highly structured viral RNA molecules by combinatorial libraries of hairpin ribozymes. The most effective ribozymes are not predicted by substrate selection rules Journal of Biological Chemistry 1998 273 36 23524 23533 (Pubitemid 28417545)
18. Lucier J. F., Bergeron L. J., Brire F. P., Ouellette R., Elela S. A., Perreault J. P., RiboSubstrates: a web application addressing the cleavage specificities of ribozymes in designated genomes BMC Bioinformatics 2006 7, article 480
19. Higgins G. A., Lewis D. A., Bahmanyar S., Goldgaber D., Gajdusek D. C., Young W. G., Morrison J. H., Wilson M. C., Differential regulation of amyloid- -protein mRNA expression within hippocampal neuronal subpopulations in Alzheimer disease Proceedings of the National Academy of Sciences of the United States of America 1988 85 4 1297 1301 (Pubitemid 18073996)
20. Moir R. D., Tanzi R. E., LRP-mediated clearance of A is inhibited by KPI-containing isoforms of APP Current Alzheimer Research 2005 2 2 269 273 (Pubitemid 40862892)
21. Reymond C., Beaudoin J. D., Perreault J. P., Modulating RNA structure and catalysis: lessons from small cleaving ribozymes Cellular and Molecular Life Sciences 2009 66 24 3937 3950
22. Huang Y., Maraia R. J., Comparison of the RNA polymerase III transcription machinery in Schizosaccharomyces pombe, Saccharomyces cerevisiae and human Nucleic Acids Research 2001 29 13 2675 2690 (Pubitemid 32685030)
23. Jackson A. L., Linsley P. S., Noise amidst the silence: off-target effects of siRNAs? Trends in Genetics 2004 20 11 521 524 (Pubitemid 39314555)
24. Lin X., Ruan X., Anderson M. G., McDowell J. A., Kroeger P. E., Fesik S. W., Shen Y., siRNA-mediated off-target gene silencing triggered by a 7nt complementation Nucleic Acids Research 2005 33 14 4527 4535 (Pubitemid 41222567)
25. Alvarez V. A., Ridenour D. A., Sabatini B. L., Retraction of synapses and dendritic spines induced by off-target effects of RNA interference Journal of Neuroscience 2006 26 30 7820 7825 (Pubitemid 44315151)
26. Judge A. D., Sood V., Shaw J. R., Fang D., McClintock K., MacLachlan I., Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA Nature Biotechnology 2005 23 4 457 462 (Pubitemid 41724921)
27. Laitala-Leinonen T., Update on the development of microRNA and siRNA molecules as regulators of cell physiology Recent Patents on DNA and Gene Sequences 2010 4 2 113 121
28. Shih I. H., Been M. D., Catalytic strategies of the hepatitis delta virus ribozymes Annual Review of Biochemistry 2002 71 887 917 (Pubitemid 34800238)
29. Bergeron L., Ouellet J., Perreault J. P., Ribozyme-based gene-inactivation systems require a fine comprehension of their substrate specificities; the case of delta ribozyme Current Medicinal Chemistry 2003 10 23 2589 2597 (Pubitemid 37456028)
30. Scherer L. J., Rossi J. J., Approaches for the sequence-specific knockdown of mRNA Nature Biotechnology 2003 21 12 1457 1465 (Pubitemid 37522705)
31. Salehi-Ashtiani K., Luptk A., Litovchick A., Szostak J. W., A genomewide search for ribozymes reveals an HDV-like sequence in the human CPEB3 gene Science 2006 313 5794 1788 1792 (Pubitemid 44454155)
32. Netzer W. J., Powell C., Nong Y., Blundell J., Wong L., Duff K., Flajolet M., Greengard P., Lowering beta-amyloid levels rescues learning and memory in a Down syndrome mouse model PloS one 2010 5 6 e10943
33. Wilcock D. M., Gharkholonarehe N., Van Nostrand W. E., Davis J., Vitek M. P., Colton C. A., Amyloid reduction by amyloid- vaccination also reduces mouse tau pathology and protects from neuron loss in two mouse models of Alzheimer's disease Journal of Neuroscience 2009 29 25 7957 7965
34. Aisen P. S., Gauthier S., Vellas B., Briand R., Saumier D., Laurin J., Garceau D., Alzhemed: a potential treatment for Alzheimer's disease Current Alzheimer Research 2007 4 4 473 478 (Pubitemid 47416642)
35. Janus C., Pearson J., McLaurin J., Mathews P. M., Jiang Y., Schmidt S. D., Chishti M. A., Horne P., Heslin D., French J., Mount H. T. J., Nixon R. A., Mercken M., Bergeron C., Fraser P. E., St George-Hyslop P., Westaway D., A peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease Nature 2000 408 6815 979 982 (Pubitemid 32101644)
36. McLaurin J., Cecal R., Kierstead M. E., Tian X., Phinney A. L., Manea M., French J. E., Lambermon M. H. L., Darabie A. A., Brown M. E., Janus C., Chishti M. A., Horne P., Westaway D., Fraser P. E., Mount H. T. J., Przybylski M., St George-Hyslop P., Therapeutically effective antibodies against amyloid- peptide target amyloid- residues 4-10 and inhibit cytotoxicity and fibrillogenesis Nature Medicine 2002 8 11 1263 1269 (Pubitemid 35373558)
37. Boche D., Denham N., Holmes C., Nicoll J. A. R., Neuropathology after active A 42 immunotherapy: implications for Alzheimer's disease pathogenesis Acta Neuropathologica 2010 120 3 369 384
38. Wang H., Song L., Laird F., Wong P. C., Lee H. K., BACE1 knock-outs display deficits in activity-dependent potentiation of synaptic transmission at mossy fiber to CA3 synapses in the hippocampus Journal of Neuroscience 2008 28 35 8677 8681
39. Savonenko A. V., Melnikova T., Laird F. M., Stewart K. A., Price D. L., Wong P. C., Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice Proceedings of the National Academy of Sciences of the United States of America 2008 105 14 5585 5590 (Pubitemid 351753906)
40. Laird F. M., Cai H., Savonenko A. V., Farah M. H., He K., Melnikova T., Wen H., Chiang H. C., Xu G., Koliatsos V. E., Borchelt D. R., Price D. L., Lee H. K., Wong P. C., BACE1, a major determinant of selective vulnerability of the brain to amyloid- amyloidogenesis, is essential for cognitive, emotional, and synaptic functions Journal of Neuroscience 2005 25 50 11693 11709 (Pubitemid 43098462)
41. Willem M., Garratt A. N., Novak B., Citron M., Kaufmann S., Rittger A., DeStrooper B., Saftig P., Birchmeier C., Haass C., Control of peripheral nerve myelination by the -secretase BACE1 Science 2006 314 5799 664 666 (Pubitemid 44646394)
42. Hu X., Hicks C. W., He W., Wong P., MacKlin W. B., Trapp B. D., Yan R., Bace1 modulates myelination in the central and peripheral nervous system Nature Neuroscience 2006 9 12 1520 1525 (Pubitemid 44862660)
43. Kim D. Y., Carey B. W., Wang H., Ingano L. A. M., Binshtok A. M., Wertz M. H., Pettingell W. H., He P., Lee V. M. Y., Woolf C. J., Kovacs D. M., BACE1 regulates voltage-gated sodium channels and neuronal activity Nature Cell Biology 2007 9 7 755 764 (Pubitemid 47019462)
44. Zhu Z., Sun Z. Y., Ye Y., Voigt J., Strickland C., Smith E. M., Cumming J., Wang L., Wong J., Wang Y. S., Wyss D. F., Chen X., Kuvelkar R., Kennedy M. E., Favreau L., Parker E., McKittrick B. A., Stamford A., Czarniecki M., Greenlee W., Hunter J. C., Discovery of cyclic acylguanidines as highly potent and selective -site amyloid cleaving enzyme (BACE) inhibitors: part Iinhibitor design and validation Journal of Medicinal Chemistry 2010 53 3 951 965
45. Klaver D. W., Wilce M. C. J., Cui H., Hung A. C., Gasperini R., Foa L., Small D. H., Is BACE1 a suitable therapeutic target for the treatment of Alzheimer's disease? Current strategies and future directions Biological Chemistry 2010 391 8 849 859
46. Imbimbo B. P., Peretto I., Semagacestat, a -secretase inhibitor for the potential treatment of Alzheimer's disease Current Opinion in Investigational Drugs 2009 10 7 721 730
47. Henley D. B., May P. C., Dean R. A., Siemers E. R., Development of semagacestat (LY450139), a functional -secretase inhibitor, for the treatment of Alzheimer's disease Expert Opinion on Pharmacotherapy 2009 10 10 1657 1664
48. Extance A., Alzheimer's failure raises questions about disease-modifying strategies Nature Reviews Drug Discovery 2010 9 10 749 750
49. McConlogue L., Buttini M., Anderson J. P., Brigham E. F., Chen K. S., Freedman S. B., Games D., Johnson-Wood K., Lee M., Zeller M., Liu W., Motter R., Sinha S., Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP transgenic mice Journal of Biological Chemistry 2007 282 36 26326 26334 (Pubitemid 47443774)
50. Castellano J. M., Kim J., Stewart F. R., Jiang H., DeMattos R. B., Patterson B. W., Fagan A. M., Morris J. C., Mawuenyega K. G., Cruchaga C., Goate A. M., Bales K. R., Paul S. M., Bateman R. J., Holtzman D. M., Human apoE isoforms differentially regulate brain amyloid- peptide clearance Science Translational Medicine 2011 3 89, article ra57
51. Takahashi M., Miyoshi H., Verma I. M., Gage F. H., Rescue from photoreceptor degeneration in the rd mouse by human immunodeficiency virus vector-mediated gene transfer Journal of Virology 1999 73 9 7812 7816 (Pubitemid 29383266)
52. Hottinger A. F., Azzouz M., Deglon N., Aebischer P., Zurn A. D., Complete and long-term rescue of lesioned adult motoneurons by lentiviral-mediated expression of glial cell line-derived neurotrophic factor in the facial nucleus Journal of Neuroscience 2000 20 15 5587 5593 (Pubitemid 30636884)
53. Lai Z., Brady R. O., Gene transfer into the central nervous system in vivo using a recombinanat lentivirus vector Journal of Neuroscience Research 2002 67 3 363 371 (Pubitemid 34137143)
54. Kordower J. H., Emborg M. E., Bloch J., Ma S. Y., Chu Y., Leventhal L., McBride J., Chen E. Y., Palfi S., Roitberg B. Z., Brown W. D., Holden J. E., Pyzalski R., Taylor M. D., Carvey P., Ling Z., Trono D., Hantraye P., Deglon N., Aebischer P., Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease Science 2000 290 5492 767 773
55. Spencer B. J., Verma I. M., Targeted delivery of proteins across the blood-brain barrier Proceedings of the National Academy of Sciences of the United States of America 2007 104 18 7594 7599 (Pubitemid 47185951)